Kidney Outcomes with Glucagon-Like Peptide-1 Receptor Agonists, Sodium-Glucose Cotransporter 2 Inhibitors, Dipeptidyl Peptidase-4 Inhibitors, and Sulfonylureas in Type 2 Diabetes and Moderate Cardiovascular Risk.

ABSTRACT:

SUBMITTER: Neumiller JJ 

PROVIDER: S-EPMC11835155 | biostudies-literature | 2024 Oct

REPOSITORIES: biostudies-literature